PCM
ATEX icon

Potomac Capital Management’s Anterix ATEX Stock Holding History

Potomac Capital Management’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,500
Closed -$578K – 70
2025
Q4 		$578K Buy
+26,500
New +$550K 0.46% 43

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
PM
Plustick Management Charlottesville, Virginia $207M AUM 253.94% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Potomac Capital Management's ATEX Position: Q1 2026 in Review

Potomac Capital Management increased its Anterix (ATEX) stake by 7.7% in Q1 2026, buying an estimated $392K and bringing the position to 173,802 shares worth $6.64M. The position accounts for 5.77% of the portfolio, ranked #2.

Potomac Capital Management first reported a position in ATEX in Q4 2025 and has held it in 2 quarters since. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Potomac Capital Management held 173,802 shares of Anterix worth $6.64M as of Q1 2026.
  • Potomac Capital Management bought 12,402 Anterix shares in Q1 2026, an estimated $392K.
  • Anterix made up 5.77% of Potomac Capital Management's portfolio in Q1 2026, its #2 holding.
  • Potomac Capital Management first reported a position in Anterix in Q4 2025 and has held it in 2 quarters since.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Potomac Capital Management's 13F filing for Q1 2026, filed 14 May 2026.